{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:29:40Z","timestamp":1790425780663,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/npp.2016.265","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T07:01:46Z","timestamp":1479970906000},"page":"1169-1177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating"],"prefix":"10.1038","volume":"42","author":[{"given":"Joonas","family":"Majuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juho","family":"Joutsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarkko","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Voon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Alakurtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Parkkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuuli","family":"Lahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Alho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Hirvonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveliina","family":"Arponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Forsback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valtteri","family":"Kaasinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,24]]},"reference":[{"key":"BFnpp2016265_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/jcbfm.2015.53","volume":"35","author":"K Alakurtti","year":"2015","unstructured":"Alakurtti K, Johansson JJ, Joutsa J, Laine M, B\u00e4ckman L, Nyberg L et al (2015). Long-term test-retest reliability of striatal and extrastriatal dopamine D2\/3 receptor binding: study with [(11)C]raclopride and high-resolution PET. J Cereb Blood Flow Metab 35: 1199\u20131205.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2016265_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrn3104","volume":"12","author":"A Badiani","year":"2011","unstructured":"Badiani A, Belin D, Epstein D, Calu D, Shaham Y (2011). Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci 12: 685\u2013700.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp2016265_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.coph.2008.12.014","volume":"9","author":"KC Berridge","year":"2009","unstructured":"Berridge KC, Robinson TE, Aldridge JW (2009). Dissecting components of reward: 'liking', 'wanting', and learning. Curr Opin Pharmacol 9: 65\u201373.","journal-title":"Curr Opin Pharmacol"},{"key":"BFnpp2016265_CR4","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/add.12946","volume":"110","author":"C Blanco","year":"2015","unstructured":"Blanco C, Hanania J, Petry NM, Wall MM, Wang S, Jin CJ et al (2015). Towards a comprehensive developmental model of pathological gambling. Addiction 110: 1340\u20131351.","journal-title":"Addiction"},{"key":"BFnpp2016265_CR5","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1038\/npp.2014.87","volume":"39","author":"MA Bloomfield","year":"2014","unstructured":"Bloomfield MA, Pepper F, Egerton A, Demjaha A, Tomasi G, Mouchlianitis E et al (2014). Dopamine function in cigarette smokers: an [(1)(8)F]-DOPA PET study. Neuropsychopharmacology 39: 2397\u20132404.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016265_CR6","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/add.12066","volume":"108","author":"I Boileau","year":"2013","unstructured":"Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM et al (2013). The D2\/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction 108: 953\u2013963.","journal-title":"Addiction"},{"key":"BFnpp2016265_CR7","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/mp.2013.163","volume":"19","author":"I Boileau","year":"2014","unstructured":"Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA et al (2014). In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Mol Psychiatry 19: 1305\u20131313.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016265_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/M15-2455","volume":"165","author":"KA Brownley","year":"2016","unstructured":"Brownley KA, Berkman ND, Peat CM, Lohr KN, Cullen KE, Bann CM et al (2016). Binge-eating disorder in adults: a systematic review and meta-analysis. Ann Intern Med 165: 409\u2013420.","journal-title":"Ann Intern Med"},{"key":"BFnpp2016265_CR9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.biopsych.2012.10.022","volume":"73","author":"VC Cambridge","year":"2013","unstructured":"Cambridge VC, Ziauddeen H, Nathan PJ, Subramaniam N, Dodds C, Chamberlain SR et al (2013). Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese people. Biol Psychiatry 73: 887\u2013894.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016265_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neuroimage.2012.06.067","volume":"63","author":"L Clark","year":"2012","unstructured":"Clark L, Stokes PR, Wu K, Michalczuk R, Benecke A, Watson BJ et al (2012). Striatal dopamine D2\/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage 63: 40\u201346.","journal-title":"Neuroimage"},{"key":"BFnpp2016265_CR11","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1088\/0031-9155\/52\/5\/019","volume":"52","author":"HW de Jong","year":"2007","unstructured":"de Jong HW, van Velden FH, Kloet RW, Buijs FL, Boellaard R, Lammertsma AA (2007). Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner. Phys Med Biol 52: 1505\u20131526.","journal-title":"Phys Med Biol"},{"key":"BFnpp2016265_CR12","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, S\u00e9gonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D et al (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31: 968\u2013980.","journal-title":"Neuroimage"},{"key":"BFnpp2016265_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C et al (2002). Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33: 341\u2013355.","journal-title":"Neuron"},{"key":"BFnpp2016265_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/jlcr.1599","volume":"52","author":"S Forsback","year":"2009","unstructured":"Forsback S, Eskola O, Bergman J, Haaparanta M, Solin O (2009). Alternative solvents for electrophilic synthesis of 6-[18F]fluoro-L-DOPA. J Labelled Combd Rad 52: 286\u2013288.","journal-title":"J Labelled Combd Rad"},{"key":"BFnpp2016265_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1017\/S1092852915000668","volume":"20","author":"C Giuliano","year":"2015","unstructured":"Giuliano C, Cottone P (2015). The role of the opioid system in binge eating disorder. CNS Spectr 20: 537\u2013545.","journal-title":"CNS Spectr"},{"key":"BFnpp2016265_CR16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.4088\/JCP.v69n0511","volume":"69","author":"JE Grant","year":"2008","unstructured":"Grant JE, Kim SW, Hartman BK (2008). A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry 69: 783\u2013789.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2016265_CR17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1192\/bjp.bp.110.078105","volume":"197","author":"JE Grant","year":"2010","unstructured":"Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW (2010a). Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry 197: 330\u2013331.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2016265_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","volume":"163","author":"JE Grant","year":"2006","unstructured":"Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G et al (2006). Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 163: 303\u2013312.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016265_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/00952990.2010.491884","volume":"36","author":"JE Grant","year":"2010","unstructured":"Grant JE, Potenza MN, Weinstein A, Gorelick DA (2010b). Introduction to behavioral addictions. Am J Drug Alcohol Abuse 36: 233\u2013241.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BFnpp2016265_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/nimg.1997.0303","volume":"6","author":"RN Gunn","year":"1997","unstructured":"Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997). Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6: 279\u2013287.","journal-title":"Neuroimage"},{"key":"BFnpp2016265_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2009.129","volume":"35","author":"SN Haber","year":"2010","unstructured":"Haber SN, Knutson B (2010). The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35: 4\u201326.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016265_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archpsyc.62.1.57","volume":"62","author":"A Heinz","year":"2005","unstructured":"Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G et al (2005). Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch General Psychiatry 62: 57\u201364.","journal-title":"Arch General Psychiatry"},{"key":"BFnpp2016265_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00259-008-0935-6","volume":"36","author":"J Hirvonen","year":"2009","unstructured":"Hirvonen J, Aalto S, Hagelberg N, Maksimow A, Ingman K, Oikonen V et al (2009). Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects. Eur J Nucl Med Mol Imaging 36: 275\u2013286.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BFnpp2016265_CR24","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.neuroimage.2012.02.006","volume":"60","author":"J Joutsa","year":"2012","unstructured":"Joutsa J, Johansson J, Niemel\u00e4 S, Ollikainen A, Hirvonen MM, Piepponen P et al (2012). Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage 60: 1992\u20131999.","journal-title":"Neuroimage"},{"key":"BFnpp2016265_CR25","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/mp.2015.153","volume":"21","author":"HK Karlsson","year":"2015","unstructured":"Karlsson HK, Tuulari JJ, Tuominen L, Hirvonen J, Honka H, Parkkola R et al (2015). Weight loss after bariatric surgery normalizes brain opioid receptors in morbid obesity. Mol Psychiatry 21: 1057\u20131062.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016265_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2967\/jnumed.111.095240","volume":"53","author":"SH Keller","year":"2012","unstructured":"Keller SH, Sibomana M, Olesen OV, Svarer C, Holm S, Andersen FL et al (2012). Methods for motion correction evaluation using 18F-FDG human brain scans on a high-resolution PET scanner. J Nucl Med 53: 495\u2013504.","journal-title":"J Nucl Med"},{"key":"BFnpp2016265_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.biopsych.2012.11.020","volume":"73","author":"RC Kessler","year":"2013","unstructured":"Kessler RC, Berglund PA, Chiu WT, Deitz AC, Hudson JI, Shahly V et al (2013). The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Biol Psychiatry 73: 904\u2013914.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016265_CR28","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1017\/S0033291708002900","volume":"38","author":"RC Kessler","year":"2008","unstructured":"Kessler RC, Hwang I, LaBrie R, Petukhova M, Sampson NA, Winters KC et al (2008). DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol Med 38: 1351\u20131360.","journal-title":"Psychol Med"},{"key":"BFnpp2016265_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1055\/s-0032-1331747","volume":"46","author":"T Kienast","year":"2013","unstructured":"Kienast T, Schlagenhauf F, Rapp MA, Wrase J, Daig I, Buchholz HG et al (2013). Dopamine-modulated aversive emotion processing fails in alcohol-dependent patients. Pharmacopsychiatry 46: 130\u2013136.","journal-title":"Pharmacopsychiatry"},{"key":"BFnpp2016265_CR30","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","volume":"49","author":"SW Kim","year":"2001","unstructured":"Kim SW, Grant JE, Adson DE, Shin YC (2001). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 49: 914\u2013921.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016265_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000435876","volume":"22","author":"L Kovanen","year":"2016","unstructured":"Kovanen L, Basnet S, Castr\u00e9n S, Pankakoski M, Saarikoski ST, Partonen T et al (2016). A randomised, double-blind, placebo-controlled trial of as-needed naltrexone in the treatment of pathological gambling. Eur Addict Res 22: 70\u201379.","journal-title":"Eur Addict Res"},{"key":"BFnpp2016265_CR32","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1038\/npp.2016.12","volume":"41","author":"C Li","year":"2016","unstructured":"Li C, Sugam JA, Lowery-Gionta EG, McElligott ZA, McCall NM, Lopez AJ et al (2016). Mu opioid receptor modulation of dopamine neurons in the periaqueductal gray\/dorsal raphe: a role in regulation of pain. Neuropsychopharmacology 41: 2122\u20132132.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016265_CR33","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1523\/JNEUROSCI.5447-07.2008","volume":"28","author":"Y Li","year":"2008","unstructured":"Li Y, van den Pol AN (2008). Mu-opioid receptor-mediated depression of the hypothalamic hypocretin\/orexin arousalsystem. J Neurosci 28: 2814\u20132819.","journal-title":"J Neurosci"},{"key":"BFnpp2016265_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pscychresns.2012.04.012","volume":"204","author":"J Linnet","year":"2012","unstructured":"Linnet J, Mouridsen K, Peterson E, M\u00f8ller A, Doudet DJ, Gjedde A (2012). Striatal dopamine release codes uncertainty in pathological gambling. Psychiatry Res 204: 55\u201360.","journal-title":"Psychiatry Res"},{"key":"BFnpp2016265_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/eat.22114","volume":"46","author":"SL McElroy","year":"2013","unstructured":"McElroy SL, Guerdjikova AI, Blom TJ, Crow SJ, Memisoglu A, Silverman BL et al (2013). A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder. Int J Eating Disord 46: 239\u2013245.","journal-title":"Int J Eating Disord"},{"key":"BFnpp2016265_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jamapsychiatry.2014.2162","volume":"72","author":"SL McElroy","year":"2015","unstructured":"McElroy SL, Hudson JI, Mitchell JE, Wilfley D, Ferreira-Cornwell MC, Gao J et al (2015). Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial. JAMA Psychiatry 72: 235\u2013246.","journal-title":"JAMA Psychiatry"},{"key":"BFnpp2016265_CR37","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/npp.2015.340","volume":"41","author":"I Mick","year":"2015","unstructured":"Mick I, Myers J, Ramos AC, Stokes PR, Erritzoe D, Colasanti A et al (2015). Blunted endogenous opioid release following an oral amphetamine challenge in pathological gamblers. Neuropsychopharmacology 41: 1742\u20131750.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016265_CR38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","volume":"5","author":"CS Patlak","year":"1985","unstructured":"Patlak CS, Blasberg RG (1985). Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 5: 584\u2013590.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2016265_CR39","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/archpsyc.62.9.1015","volume":"62","author":"MN Potenza","year":"2005","unstructured":"Potenza MN, Xian H, Shah K, Scherrer JF, Eisen SA (2005). Shared genetic contributions to pathological gambling and major depression in men. Arch Gen Psychiatry 62: 1015\u20131021.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2016265_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.conb.2014.09.005","volume":"30","author":"TW Robbins","year":"2015","unstructured":"Robbins TW, Clark L (2015). Behavioral addictions. Curr Opin Neurobiol 30: 66\u201372.","journal-title":"Curr Opin Neurobiol"},{"key":"BFnpp2016265_CR41","doi-asserted-by":"crossref","unstructured":"Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (2010). Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev CD001867.","DOI":"10.1002\/14651858.CD001867.pub3"},{"key":"BFnpp2016265_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/10550490902787007","volume":"18","author":"T Toneatto","year":"2009","unstructured":"Toneatto T, Brands B, Selby P (2009). A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling. Am J Addict 18: 219\u2013225.","journal-title":"Am J Addict"},{"key":"BFnpp2016265_CR43","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/mp.2014.58","volume":"19","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Tomasi D, Wang GJ, Logan J, Alexoff DL, Jayne M et al (2014). Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers. Mol Psychiatry 19: 1037\u20131043.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016265_CR44","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1017\/S1092852915000681","volume":"20","author":"V Voon","year":"2015","unstructured":"Voon V (2015). Cognitive biases in binge eating disorder: the hijacking of decision making. CNS Spectr 20: 566\u2013573.","journal-title":"CNS Spectr"},{"key":"BFnpp2016265_CR45","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/oby.2011.27","volume":"19","author":"GJ Wang","year":"2011","unstructured":"Wang GJ, Geliebter A, Volkow ND, Telang FW, Logan J, Jayne MC et al (2011). Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity 19: 1601\u20131608.","journal-title":"Obesity"},{"key":"BFnpp2016265_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V et al (2010). Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67: 589\u2013595.","journal-title":"Arch Neurol"},{"key":"BFnpp2016265_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00004728-199801000-00027","volume":"22","author":"RP Woods","year":"1998","unstructured":"Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC (1998). Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22: 139\u2013152.","journal-title":"J Comput Assist Tomogr"},{"key":"BFnpp2016265_CR48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0893-133X(97)00089-4","volume":"17","author":"JC Wu","year":"1997","unstructured":"Wu JC, Bell K, Najafi A, Widmark C, Keator D, Tang C et al (1997). Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neuropsychopharmacology 17: 402\u2013409.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016265_CR49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/HRP.0000000000000051","volume":"23","author":"YH Yau","year":"2015","unstructured":"Yau YH, Potenza MN (2015). Gambling disorder and other behavioral addictions: recognition and treatment. Harv Rev Psychiatry 23: 134\u2013146.","journal-title":"Harv Rev Psychiatry"},{"key":"BFnpp2016265_CR50","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/mp.2012.154","volume":"18","author":"H Ziauddeen","year":"2013","unstructured":"Ziauddeen H, Chamberlain SR, Nathan PJ, Koch A, Maltby K, Bush M et al (2013). Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects. Mol Psychiatry 18: 1287\u20131293.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016265_CR51","first-page":"1225","volume":"2","author":"JK Zubieta","year":"1996","unstructured":"Zubieta JK, Gorelick DA, Stauffer R, Ravert HT, Dannals RF, Frost JJ (1996). Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. NatMed 2: 1225\u20131229.","journal-title":"NatMed"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2016265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2016265","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2016265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:56:39Z","timestamp":1684439799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2016265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,24]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFnpp2016265"],"URL":"https:\/\/doi.org\/10.1038\/npp.2016.265","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,24]]},"assertion":[{"value":"7 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}